UKE - University Cancer Center Hamburg - Hubertus Wald Tumor Center

Quality Report 2022 / 2023

Download | pdf | 1,40 MB
Quality report based on the regulations of the Federal Joint Committee on the specification of the special tasks of centers and focal points pursuant to Section 136c (5) SGB V (center regulations)

Facts & figures

The Hubertus Wald Tumor Center - University Cancer Center Hamburg (UCCH) has been certified as an Oncology Center by the German Cancer Society (DKG) since 2011. The UCCH has been certified as an Oncology Center of Excellence by the German Cancer Aid (DKH) since 2009. The certification requirements are reviewed annually as part of an audit and are considered a standardized way of verifying excellent cancer care and special attention for our patients.

Aim

The aim of this coordinative network is to provide optimal individual tumor medical care for patients and to consistently develop clinical and translational research in the Hamburg metropolitan region. Personalized therapy concepts are offered on the basis of molecular biological analyses. In addition to therapy and research, we take care of the individual well-being of patients through numerous additional offers (e.g. music, art, sports therapy, nutrition, etc.) and have also further developed prevention and aftercare concepts.

Since 2015, we have been the first German state to implement the amended regional cancer registry law (Hamburg) with close cooperation of the clinical cancer registry at UKE, which is coordinated by UCCH. The Hamburg Cancer Registry (HKR) was founded in 1926, making it the oldest of its kind in the world.

History

2004
First certification as a breast center at the UKE (DKG - Organ Cancer Center)

2007
Foundation & start of the Universitäres Cancer Center Hamburg (UCCH) and certification by the
DGHO as an Oncological Center

2007
Initial certification as a Prostate Center (DKG - Organ Cancer Center)

2009
Award and start of the 1st funding period by the DKH as Oncology Center of Excellence

2009
Overall certification of the UKE according to DIN ISO 9001 (first hospital in Germany)

2009
Certification as a family-friendly company, as well as according to criteria on
Patient Safety and Ethics & Values

2009
First certification as Gynecological Cancer Center (DKG - Organ Cancer Center) with certified Dysplasia Unit since 2015

2010
Establishment of a Central Entry Port, a central administration and an outpatient clinic for all cancer patients

2011
Initial certification as superordinate Oncological Center (DKG) with Head-Neck Tumor Center (organ cancer center)

2013
Second honouring and founding by the DKH as an Interdisciplinary Oncological Center of Excellence

2014
Initial certification as Colon Cancer Center (DKG - organ cancer center)

2016
Renewed award and start of 3rd funding period by DKH as an Interdisciplinary Oncological Center of Excellence

2017
Initial certification of the ENETS Center for Excellence - European certification as a center of excellence for neuroendocrine tumors

2019
Initial certification as Skin Cancer Center (DKG - organ cancer center)

2020/21
Initial certification Pediatric Oncology Center (DKG Organ Cancer Center)
Partnership Mammazentrum Hamburg and Jerusalem Krankenhaus

2021
Initial certification Center for Familial Breast and Ovarian Cancer
Uro-oncology center (expansion of the prostate center to include bladder and kidney)

2022
Initial certification Sarcoma Center
Initial certification Visceral Oncology Center (expansion to include liver focus)
Initial certification Center for Haematological Neoplasia

2023
Initial certification Centre for Personalized Medicine - Oncology

Patient care

At the UCCH patients are cared for covering the whole range of oncological and hematological diseases. According to the treatment method (chemotherapy, radiation therapy, surgery etc.) patients are either treated stationary or in our outpatient department.

The UCCH consists of all major facilities necessary for the treatement of oncological and hematological patients and operates according to newest scientific findings and predefined treatment plans. One main focus lies on the personalized cancer medicine. Based on interdisciplinary tumor conferences and liaision services there is a close joint work with all cooperating departments and external partners in the metropolitian area of Hamburg.

many cancer patients of the UKE reach us via our central registration portal
many patients are trans-regional
Palliative medical focus at the UKE with ESMO certification, recognition by the DKG and certificate of the German Society for Palliative Medicine
More than 30 specialized outpatient clinics for different entities (tumors)
13 specialized outpatient clinics for e.g. complementary medicine, hereditary tumors, second opinion, prevention and personalized medicine UCCH Consultation overview
Survivorship program for patients
Focus on psycho-oncological care and research (> 7.600 consultations/year)
Close cooperation with more than >40 patient support groups
Patient competence center and patient ambassadors (DE)

The UCCH in numbers

> 6,100 newly diagnosed and >10,800 treated oncology patients/year
Treatment of > 20,000 outpatient oncology patients/year within the UCCH
> 16,000 individual concepts for the treatment of our patients per year are developed in interdisciplinary tumor conferences
Approx. 20% of these concepts are based on individual, molecular analyses

Status: 02/2024

Clinical studies

>6,000 UCCH patients are being treated in interventional clinical trials
Tool: "Trial Finder" for internal and external quick search of currently open trials
Joint study management with cooperation partners

Status: 02/2024

Research

Cross-center research programs on dissemination and metastasis, prostate cancer, leukemias and lymphomas, neuro-oncology, gastrointestinal tumors & immuno-oncology and cancer epidemiology
> 36 working groups in the service of experimental, clinical, translational and epidemiological cancer research
> 600 cancer-related publications per year

Status: 02/2024

Quality

47 evidence-based pathways for diagnostics, therapy and follow-up care
24 interdisciplinary tumor boards per week
Central units: UCCH Cancer Registry, UCCH Study Center, UCCH Biobank, ECTU, Central Contact Point, UCCH Core Unit (Central Administration)
Management of the cancer-relevant bio- and tissue banks at the UKE
Regular evaluation of the implementation of tumor board decisions and the management system

Employees

>500 physicians, researchers and clinical and administrative staff in the service of cancer medicine

Executive Board

The structure of the UCCH is divided into three hierarchical layers:
1.) UCCH Executive Board,
2.) Board Council,
3.) Meeting of Members.

UCCH Executive Board